To gain a few extra centimeters in height, teenagers are using powerful anticancer drugs, putting their own health at serious risk.
The drug in question is erdatinib, a potent treatment approved for certain adults with advanced urothelial cancer, though it has also been used—off-label—in children to treat brain tumors. The finding that these children experienced rapid growth while taking the drug sparked interest among social media users seeking ways to grow taller, even through unapproved treatments.
This has alarmed experts worldwide, who are sounding the alarm.
“Serious genetic complications have also been documented there. The way the drug works is by inhibiting certain factors that promote tumor growth, and one of these factors normally limits bone elongation once growth has ceased, in adulthood. As a result of an adverse effect caused by the medication, the child grows taller more rapidly for a few months, but this does not mean that they will be taller as an adult.”
Christos Petrou – Professor of Pharmacy, University of Nicosia
The European Medicines Agency has documented the link between the medication and the occurrence of this specific side effect.
“Under no circumstances is height increase an approved indication, nor can it be considered a therapeutic option.”
Christos Petrou – Professor of Pharmacy, University of Nicosia
In a scientific publication by researchers at the U.S. Food and Drug Administration, five cases are documented in which children aged 10 to 15 experienced severe skeletal growth disorders while taking erdatinib. Three of these cases required surgery.
Watch the report by Rafaella Stavrinou:
READ ALSO: VIDEO: Explosion at a naval base in Benghazi; Ukrainian attack on a moored Russian ship suspected | AlphaNews
